{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:16:04Z","timestamp":1791821764624,"version":"4.3.4"},"reference-count":28,"publisher":"Siapec Servizi Srl","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-1659","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:31:08Z","timestamp":1775737868000},"page":"588-597","source":"Crossref","is-referenced-by-count":2,"title":["Immunohistochemical and molecular profiling of uveal melanoma: clinicopathological correlations from an Italian cohort"],"prefix":"10.32074","volume":"117","author":[{"given":"Francesco","family":"Fortarezza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Zarrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Munari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Angerilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Balistreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Piccin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Balistreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Salizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Pigozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Midena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Parrozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Midena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sbaraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Paolo","family":"Dei Tos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2026,2]]},"reference":[{"key":"10.32074\/1591-951X-1659_ref1","doi-asserted-by":"crossref","unstructured":"Spagnolo F, Caltabiano G, Queirolo P. Uveal melanoma. Cancer Treat Rev. 2012;38(5):549-553. https:\/\/doi.org\/10.1016\/j.ctrv.2012.01.002","DOI":"10.1016\/j.ctrv.2012.01.002"},{"key":"10.32074\/1591-951X-1659_ref2","doi-asserted-by":"crossref","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664-1678. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19981015)83:8 < 1664::aid-cncr23 > 3.0.co;2-g","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G"},{"key":"10.32074\/1591-951X-1659_ref3","doi-asserted-by":"crossref","unstructured":"Damato B. Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther. 2006;6(4):493-506. https:\/\/doi.org\/10.1586\/14737140.6.4.493","DOI":"10.1586\/14737140.6.4.493"},{"key":"10.32074\/1591-951X-1659_ref4","doi-asserted-by":"crossref","unstructured":"Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol. 2005;140(4):612-617. https:\/\/doi.org\/10.1016\/j.ajo.2005.05.034","DOI":"10.1016\/j.ajo.2005.05.034"},{"key":"10.32074\/1591-951X-1659_ref5","doi-asserted-by":"crossref","unstructured":"Yonekawa Y, Kim IK. Epidemiology and management of uveal melanoma. Hematol Oncol Clin North Am. 2012;26(6):1169-1184. https:\/\/doi.org\/10.1016\/j.hoc.2012.08.004","DOI":"10.1016\/j.hoc.2012.08.004"},{"key":"10.32074\/1591-951X-1659_ref6","doi-asserted-by":"crossref","unstructured":"Singh M, Durairaj P, Yeung J. Uveal Melanoma: A Review of the Literature. Oncol Ther. 2018 Jun;6(1):87-104. https:\/\/doi.org\/ 10.1007\/s40487-018-0056-8. Epub 2018 Feb 6. Erratum in: Oncol Ther. 2019 Jun;7(1):93. https:\/\/doi.org\/ 10.1007\/s40487-019-0093-y. PMID: 32700136; PMCID: PMC7359963.","DOI":"10.1007\/s40487-018-0056-8"},{"key":"10.32074\/1591-951X-1659_ref7","doi-asserted-by":"crossref","unstructured":"Mariani P, Torossian N, van Laere S, Vermeulen P, de Koning L, Roman-Roman S, Lantz O, Rodrigues M, Stern MH, Gardrat S, Lesage L, Champenois G, Nicolas A, Matet A, Cassoux N, Servois V, Romano E, Piperno-Neumann S, Lugassy C, Barnhill R. Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases. Br J Cancer. 2023 Sep;129(5):772-781. https:\/\/doi.org\/ 10.1038\/s41416-023-02331-w. Epub 2023 Jul 13. PMID: 37443346; PMCID: PMC10449826.","DOI":"10.1038\/s41416-023-02331-w"},{"key":"10.32074\/1591-951X-1659_ref8","doi-asserted-by":"crossref","unstructured":"Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients. Ophthalmology. 2013;120(10):2066-2071. https:\/\/doi.org\/10.1016\/j.ophtha.2013.03.012","DOI":"10.1016\/j.ophtha.2013.03.012"},{"key":"10.32074\/1591-951X-1659_ref9","doi-asserted-by":"crossref","unstructured":"Robertson AG, Shih J, Yau C, et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma [published correction appears in Cancer Cell. 2018 Jan 8;33(1):151. https:\/\/doi.org\/ 10.1016\/j.ccell.2017.12.013.]. Cancer Cell. 2017;32(2):204-220.e15. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.003","DOI":"10.1016\/j.ccell.2017.07.003"},{"key":"10.32074\/1591-951X-1659_ref10","doi-asserted-by":"crossref","unstructured":"Fortarezza F, Cazzato G, Ingravallo G, Dei Tos AP. The 2023 WHO updates on skin tumors: advances since the 2018 edition. Pathologica. 2024;116(4):193-206. https:\/\/doi.org\/10.32074\/1591-951X-1006","DOI":"10.32074\/1591-951X-1006"},{"key":"10.32074\/1591-951X-1659_ref11","doi-asserted-by":"crossref","unstructured":"P\u0103s\u0103ric\u0103 MA, Curc\u0103 PF, Dragosloveanu CDM, Grigorescu AC, Nisipa\u0219u CI. Pathological and Molecular Diagnosis of Uveal Melanoma. Diagnostics (Basel). 2024 May 2;14(9):958. https:\/\/doi.org\/ 10.3390\/diagnostics14090958. PMID: 38732371; PMCID: PMC11083017.","DOI":"10.3390\/diagnostics14090958"},{"key":"10.32074\/1591-951X-1659_ref12","doi-asserted-by":"crossref","unstructured":"Matull J, Placke JM, Lodde G, Zaremba A, Utikal J, Terheyden P, Pf\u00f6hler C, Herbst R, Kreuter A, Welzel J, Kretz J, M\u00f6ller I, Sucker A, Paschen A, Livingstone E, Zimmer L, Hadaschik E, Ugurel S, Schadendorf D, Thielmann CM, Griewank KG. Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma. Front Immunol. 2024 Jun 5;15:1383125. https:\/\/doi.org\/ 10.3389\/fimmu.2024.1383125. PMID: 38903495; PMCID: PMC11188379.","DOI":"10.3389\/fimmu.2024.1383125"},{"key":"10.32074\/1591-951X-1659_ref13","doi-asserted-by":"crossref","unstructured":"Han LM, Lee KW, Uludag G, et al. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas. Mod Pathol. 2023;36(4):100081. https:\/\/doi.org\/10.1016\/j.modpat.2022.100081","DOI":"10.1016\/j.modpat.2022.100081"},{"key":"10.32074\/1591-951X-1659_ref14","doi-asserted-by":"crossref","unstructured":"Koopmans AE, Verdijk RM, Brouwer RW, et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol. 2014;27(10):1321-1330. https:\/\/doi.org\/10.1038\/modpathol.2014.43","DOI":"10.1038\/modpathol.2014.43"},{"key":"10.32074\/1591-951X-1659_ref15","doi-asserted-by":"crossref","unstructured":"Linos K, Atkinson AE, Yan S, Tsongalis GJ, Lefferts JA. A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor. J Cutan Pathol. 2020;47(5):485-489. https:\/\/doi.org\/10.1111\/cup.13642","DOI":"10.1111\/cup.13642"},{"key":"10.32074\/1591-951X-1659_ref16","doi-asserted-by":"crossref","unstructured":"Figueiredo CR, Kalirai H, Sacco JJ, Azevedo RA, Duckworth A, Slupsky JR, Coulson JM, Coupland SE. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. J Pathol. 2020 Apr;250(4):420-439. https:\/\/doi.org\/ 10.1002\/path.5384. PMID: 31960425; PMCID: PMC7216965.","DOI":"10.1002\/path.5384"},{"key":"10.32074\/1591-951X-1659_ref17","doi-asserted-by":"crossref","unstructured":"Shin JS, Ha JH, Chi SW. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy. Biochem Biophys Res Commun. 2014;443(3):882-887. https:\/\/doi.org\/10.1016\/j.bbrc.2013.12.054","DOI":"10.1016\/j.bbrc.2013.12.054"},{"key":"10.32074\/1591-951X-1659_ref18","doi-asserted-by":"crossref","unstructured":"Li B, Ogasawara AK, Yang R, et al. KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF. Hypertension. 2002;39(6):1095-1100. https:\/\/doi.org\/10.1161\/01.hyp.0000018588.56950.7a","DOI":"10.1161\/01.HYP.0000018588.56950.7A"},{"key":"10.32074\/1591-951X-1659_ref19","doi-asserted-by":"crossref","unstructured":"Yang H, Jager MJ, Grossniklaus HE. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci. 2010;51(6):2835-2842. https:\/\/doi.org\/10.1167\/iovs.09-4755","DOI":"10.1167\/iovs.09-4755"},{"key":"10.32074\/1591-951X-1659_ref20","doi-asserted-by":"crossref","unstructured":"Geng Y, Geng Y, Liu X, et al. PI3K\/AKT\/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients. Front Oncol. 2023;13:1167930. Published 2023 Apr 20. https:\/\/doi.org\/10.3389\/fonc.2023.1167930","DOI":"10.3389\/fonc.2023.1167930"},{"key":"10.32074\/1591-951X-1659_ref21","doi-asserted-by":"crossref","unstructured":"Asnaghi L, Ebrahimi KB, Schreck KC, et al. Notch signaling promotes growth and invasion in uveal melanoma. Clin Cancer Res. 2012;18(3):654-665. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1406","DOI":"10.1158\/1078-0432.CCR-11-1406"},{"key":"10.32074\/1591-951X-1659_ref22","doi-asserted-by":"crossref","unstructured":"Zhang R, Han J, Daniels D, Huang H, Zhang Z. Detecting the H3F3A mutant allele found in high-grade pediatric glioma by real-time PCR. J Neurooncol. 2016;126(1):27-36. https:\/\/doi.org\/10.1007\/s11060-015-1936-5","DOI":"10.1007\/s11060-015-1936-5"},{"key":"10.32074\/1591-951X-1659_ref23","doi-asserted-by":"crossref","unstructured":"Guo J, Zhang R, Yang Z, Duan Z, Yin D, Zhou Y. Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer. Front Oncol. 2021;11:644857. Published 2021 Apr 26. https:\/\/doi.org\/10.3389\/fonc.2021.644857","DOI":"10.3389\/fonc.2021.644857"},{"key":"10.32074\/1591-951X-1659_ref24","doi-asserted-by":"crossref","unstructured":"Zhang C, Xiao J, Fa L, et al. Identification of co-expressed gene networks promoting CD8+ T cell infiltration and having prognostic value in uveal melanoma. BMC Ophthalmol. 2023;23(1):354. Published 2023 Aug 10. https:\/\/doi.org\/10.1186\/s12886-023-03098-7","DOI":"10.1186\/s12886-023-03098-7"},{"key":"10.32074\/1591-951X-1659_ref25","doi-asserted-by":"crossref","unstructured":"Thomis DC, Berg LJ. The role of Jak3 in lymphoid development, activation, and signaling. Curr Opin Immunol. 1997;9(4):541-547. https:\/\/doi.org\/10.1016\/s0952-7915(97)80108-2","DOI":"10.1016\/S0952-7915(97)80108-2"},{"key":"10.32074\/1591-951X-1659_ref26","doi-asserted-by":"crossref","unstructured":"Benhassine M, Le-Bel G, Gu\u00e9rin SL. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma. Int J Mol Sci. 2022;23(3):1564. Published 2022 Jan 29. https:\/\/doi.org\/10.3390\/ijms23031564","DOI":"10.3390\/ijms23031564"},{"key":"10.32074\/1591-951X-1659_ref27","doi-asserted-by":"crossref","unstructured":"Schoenfield L, Janse S, Kline D, Aronow ME, Singh AD, Craven C, Abdel-Rahman M, Cebulla CM. Estrogen Receptor Is Expressed in Uveal Melanoma: A Potential Target for Therapy. Ocul Oncol Pathol. 2021 Sep;7(4):303-310. https:\/\/doi.org\/ 10.1159\/000512174. Epub 2021 May 7. PMID: 34604204; PMCID: PMC8443923.","DOI":"10.1159\/000512174"},{"key":"10.32074\/1591-951X-1659_ref28","doi-asserted-by":"crossref","unstructured":"Tanaka R, Terai M, Londin E, Sato T. The Role of HGF\/MET Signaling in Metastatic Uveal Melanoma. Cancers (Basel). 2021 Oct 30;13(21):5457. https:\/\/doi.org\/ 10.3390\/cancers13215457. PMID: 34771620; PMCID: PMC8582360.","DOI":"10.3390\/cancers13215457"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:33:02Z","timestamp":1775737982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-1659","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"article-number":"6"}}